BRPI0810725A2 - Método e uso de um método para determinar um haplótipo de drb em uma amostra, e, uso do kit. - Google Patents

Método e uso de um método para determinar um haplótipo de drb em uma amostra, e, uso do kit.

Info

Publication number
BRPI0810725A2
BRPI0810725A2 BRPI0810725A BRPI0810725A2 BR PI0810725 A2 BRPI0810725 A2 BR PI0810725A2 BR PI0810725 A BRPI0810725 A BR PI0810725A BR PI0810725 A2 BRPI0810725 A2 BR PI0810725A2
Authority
BR
Brazil
Prior art keywords
haplot
drb
kit
sample
drb haplot
Prior art date
Application number
Other languages
English (en)
Inventor
Ronald Edward Bontrop
Gabriele Gerda Maria Doxiadis
Original Assignee
Stichting Biomedical Primate Res Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07105879A external-priority patent/EP1980625A1/en
Application filed by Stichting Biomedical Primate Res Ct filed Critical Stichting Biomedical Primate Res Ct
Publication of BRPI0810725A2 publication Critical patent/BRPI0810725A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI0810725 2007-04-10 2008-04-10 Método e uso de um método para determinar um haplótipo de drb em uma amostra, e, uso do kit. BRPI0810725A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07105879A EP1980625A1 (en) 2007-04-10 2007-04-10 Means and methods for haplotyping MHC-DRB loci in mammals and uses thereof
EP07107288 2007-05-01
PCT/NL2008/050199 WO2008123777A1 (en) 2007-04-10 2008-04-10 Means and methods for haplotyping mhc-drb loci in mammals and uses thereof

Publications (1)

Publication Number Publication Date
BRPI0810725A2 true BRPI0810725A2 (pt) 2014-10-21

Family

ID=39645590

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810725 BRPI0810725A2 (pt) 2007-04-10 2008-04-10 Método e uso de um método para determinar um haplótipo de drb em uma amostra, e, uso do kit.

Country Status (5)

Country Link
US (2) US9127315B2 (pt)
EP (1) EP2140030B1 (pt)
BR (1) BRPI0810725A2 (pt)
CA (1) CA2688619C (pt)
WO (1) WO2008123777A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008123777A1 (en) * 2007-04-10 2008-10-16 Stichting Biomedical Primate Research Centre Means and methods for haplotyping mhc-drb loci in mammals and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192659A (en) * 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5908749A (en) 1995-02-17 1999-06-01 Tge Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for high resolution HLA typing
US20030108940A1 (en) 2000-11-15 2003-06-12 Hidetoshi Inoko Novel polymorphic microsatellite markers in the human MHC class II region
WO2008123777A1 (en) 2007-04-10 2008-10-16 Stichting Biomedical Primate Research Centre Means and methods for haplotyping mhc-drb loci in mammals and uses thereof

Also Published As

Publication number Publication date
US20160002728A1 (en) 2016-01-07
US20100112580A1 (en) 2010-05-06
EP2140030A1 (en) 2010-01-06
US9879323B2 (en) 2018-01-30
US9127315B2 (en) 2015-09-08
EP2140030B1 (en) 2014-01-08
CA2688619C (en) 2017-06-27
WO2008123777A1 (en) 2008-10-16
CA2688619A1 (en) 2008-10-16

Similar Documents

Publication Publication Date Title
BRPI0911297A2 (pt) composição e métodos para preparo e uso das mesmas
BRPI0920891A2 (pt) misturas de alfa-amilase e métodos para uso das referidas misturas
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BRPI0916630A2 (pt) composições para uso em construção e processo de aplicação das mesmas
BRPI0906478A2 (pt) anticorpo anti-nr10 e uso do mesmo
BRPI0822104A2 (pt) Composições antimicrobianas e métodos para o uso das mesmas
BR112013001423A2 (pt) método, método in vitro, uso e kit útil para realizar o método
BRPI0820556A2 (pt) Bactéria e métodos para uso das mesmas
BRPI0819338A2 (pt) Preparações, métodos e kits úteis para o tratamento de tosse
BRPI0821668A2 (pt) Uso
BRPI0813770A2 (pt) Composição, e, uso de uma composição
BRPI0913739A2 (pt) Composição líquida, método, e, uso de composição
BRPI0907663A8 (pt) composição que compreende hfo- 123 yf, composição que compreende hcfc-243db, composição que compreende hcfo- 1233xf, composição que comproeende hcfc- 244bb, uso das composições e método de uso das composições
BRPI0920263A2 (pt) composto, uso do composto, composição, e, método
BRPI0918101A2 (pt) método para medir a troponina i em uma amostra, cartucho para ser utilizado em um dispositivo de ensaio e uso
BRPI0819299A2 (pt) Uso de composição, e, composição contendo proteína
BRPI0813947A2 (pt) Uso de estriol em baixas doses
BRPI1006996A2 (pt) composição, método e uso
PT2119778E (pt) Método para ativação de célula t auxiliar e composição para utilização no método
BRPI1009528A2 (pt) ferramenta de fundo de poço para a análise de líquidos no fundo de poço, método e método para uso em uma ferramenta de poço
BRPI0917728A2 (pt) composição, uso da composição, e, método de prevenção da formação de espuma em uma composição
BRPI0914793A2 (pt) Composição, e, uso de uma composição
BRPI0909885A2 (pt) composição decorativa e método para sua utilização
BRPI0818641A2 (pt) Rótulo, e, uso do rótulo
BR112012016229A2 (pt) método para melhorar a sobrevida livre de progressão, método in vitro, kit, uso de um oligonucleotídeo ou polipetídeo e uso de bevacizumab

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL

B350 Update of information on the portal [chapter 15.35 patent gazette]